What Happened?
San Francisco, CA-based Genome Medical Appointed Mark Sylvester as Chief Financial Officer and Corporate Development
About the Company
Our vision is a world where genomic information is fully accessible, understandable and integrated into health and well being. We are on a mission to help patients and healthcare providers use genetic services to improve health, lower the cost of care, and prevent disease.
About the Person
Mark Sylvester is Chief Financial Officer and Corporate Development at Genome Medical. Previously, Mark held various senior HR leadership roles in the industry.
Info Source
News
Short Profile